mRNA-1273.251 and mRNA-1283.251 vaccines expressing SARS-CoV-2 variant LP.8.1 antigens broadly neutralize JN.1-lineage viruses
Molecular Therapy: Nucleic Acids
· Elsevier
Аннотация
Publication date: Available online 6 November 2026 Source: Molecular Therapy Nucleic Acids Author(s): Arshan Nasir, Diana Wing Lee, Ziqiu Wang, Clinton Ogega, Nathen Bopp, Phylicia Wisti, Daniel Makrinos, Hardik Jani, Amy Gorrie, Michael F. Bender, Adrian R. Laciak, Arvind Sharma, Xiaozhen Hu, Tessa Speidel, Fadi Ghantous, Daniela Montes Berrueta, Yixuan Jacob Hou, Madelyn Severson, Allyson Langley, Kath Hardcastle
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Поиск и разработка лекарств»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
mRNA-1273.251 and mRNA-1283.251 vaccines expressing SARS-CoV-2 variant LP.8.1 antigens broadly neutralize JN.1-lineage viruses. // Molecular Therapy: Nucleic Acids. – URL: https://www.sciencedirect.com/science/article/pii/S2162253126003495?dgcid=rss_sd_all
mRNA-1273.251 and mRNA-1283.251 vaccines expressing SARS-CoV-2 variant LP.8.1 antigens broadly neutralize JN.1-lineage viruses. Molecular Therapy: Nucleic Acids. https://www.sciencedirect.com/science/article/pii/S2162253126003495?dgcid=rss_sd_all
“mRNA-1273.251 and mRNA-1283.251 vaccines expressing SARS-CoV-2 variant LP.8.1 antigens broadly neutralize JN.1-lineage viruses.” Molecular Therapy: Nucleic Acids.
@article{article117405,
title = {mRNA-1273.251 and mRNA-1283.251 vaccines expressing SARS-CoV-2 variant LP.8.1 antigens broadly neutralize JN.1-lineage viruses},
journal = {Molecular Therapy: Nucleic Acids},
url = {https://www.sciencedirect.com/science/article/pii/S2162253126003495?dgcid=rss_sd_all}
}